{
  "docId": "019de076-9b15-737c-b05c-8347f7a98ad7",
  "docSlug": "10fcfebbf5ba7c34c2d4aec7e3b05ed6",
  "documentTitle": "Enochian Biosciences | Investor Presentation Deck | 28 slides",
  "authorId": "enochian-biosciences",
  "authorName": "Renovaro Biosciences",
  "documentKindSlug": "pitchdeck",
  "documentKindLabel": "Pitch deck",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2024-01-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 6,
  "pageCount": 28,
  "prevPage": 5,
  "nextPage": 7,
  "slideType": "traction",
  "function": "show_traction",
  "density": "balanced",
  "nDataPoints": 1,
  "notes": null,
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de076-9b15-737c-b05c-8347f7a98ad7/6",
  "deckHref": "/decks/019de076-9b15-737c-b05c-8347f7a98ad7",
  "deckJsonHref": "/decks/019de076-9b15-737c-b05c-8347f7a98ad7.json",
  "deckAnchorHref": "/decks/019de076-9b15-737c-b05c-8347f7a98ad7#slide-6",
  "components": [
    {
      "bbox": {
        "h": 0.25,
        "w": 0.65,
        "x": 0.07,
        "y": 0.52
      },
      "kind": "list",
      "text": "80-90% decrease in pancreas tumor size (weight and volume)\nSignificant infiltration of tumor sac by effector immune cells\nSignificant peripheral T and NK Cell immune activation\nNo metastases",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "1ec51cb6-6fda-4ee4-9cc8-15822824845d",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.18,
        "w": 0.85,
        "x": 0.1,
        "y": 0.29
      },
      "kind": "list",
      "text": "Untreated tumor\nTumor treated with untransduced Dendritic Cells (mainstream cancer vaccine approach)\nTumor treated with vector control transduced Dendritic Cells",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "e4cd390a-50bf-421a-abb4-28dcf698fa94",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.04,
        "w": 0.5,
        "x": 0.07,
        "y": 0.24
      },
      "kind": "paragraph",
      "text": "RENB-DC11 treated animals compared to controls",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "287cb024-56b8-4ff2-882a-0e0ad0da4fa6",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.13,
        "w": 0.85,
        "x": 0.07,
        "y": 0.06
      },
      "kind": "title",
      "text": "LEADING EFFICACY FOR THERAPEUTIC VACCINES IN PRECLINICAL MODELS FOR HUMAN SOLID TUMORS",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "1147e6a7-9247-4e0f-82d7-811d4d700636",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [
    {
      "name": "List presentation",
      "slug": "list-presentation",
      "agent": null,
      "layer": "slide",
      "matchId": "cb838975-3062-4ee5-8c00-e235a7ca3efc",
      "evidence": "list/bullet: 80-90% decrease in pancreas tumor size (weight and volume) Significant infiltration of tumor sac by effector immune cells Significant peripheral T and NK Cell immune activation No metastases",
      "confidence": 0.8
    }
  ],
  "frameworks": [],
  "arcBeats": [
    {
      "to": 28,
      "from": 5,
      "beatId": "aa98e201-f5e8-4447-bd2f-449a0dcae7fe",
      "arcName": "Problem-Agitate-Solution",
      "arcSlug": "problem-agitate-solution",
      "beatName": "Solution (Provide relief)",
      "beatSlug": "problem-agitate-solution-solution-provide-relief",
      "evidence": "The presentation presents RENB-DC11 as a solution, highlighting its efficacy, manufacturing process, and potential for personalized, precision medicine.",
      "position": 2,
      "confidence": 0.9,
      "parentBeatName": "Resolution",
      "parentBeatSlug": "resolution"
    },
    {
      "to": 23,
      "from": 6,
      "beatId": "e9f4dbab-2213-495c-a809-8e8d52f9ed37",
      "arcName": "Problem-Agitate-Solution",
      "arcSlug": "problem-agitate-solution",
      "beatName": "Evidence & Proof",
      "beatSlug": "consultants-gambit-evidence-proof",
      "evidence": "The presentation provides evidence of RENB-DC11's efficacy in preclinical models.",
      "position": 3,
      "confidence": 0.9,
      "parentBeatName": "Evidence",
      "parentBeatSlug": "evidence"
    }
  ],
  "loops": [
    {
      "to": 6,
      "from": 4,
      "name": "Logic Chain",
      "slug": "01-logic-chain",
      "bestFor": "Skeptical audiences, controversial recommendations, rigorous analysis",
      "matchId": "1a0c31bd-83b1-44a2-a585-7a9095367a87",
      "evidence": "The presentation logically connects the market opportunity to RENB-DC11's potential.",
      "position": 0,
      "objective": "What is the market opportunity for RENB-DC11?",
      "structure": "Premise 1 (Accepted truth) -> Premise 2 (Observed fact) -> Therefore... (Inevitable conclusion)",
      "confidence": 0.8,
      "description": "Build an airtight chain of logic where each premise leads inevitably to the conclusion"
    }
  ],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}